4-aminopyridine has been researched along with Coronary Disease in 7 studies
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Verapamil is a widely used Ca(2+) channel antagonist in the treatment of cardiovascular disorders including atrial arrhythmias." | 1.32 | Inhibition of ultra-rapid delayed rectifier K+ current by verapamil in human atrial myocytes. ( Chiu, SW; Gao, Z; Lau, CP; Li, GR, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Z | 1 |
| Lau, CP | 1 |
| Chiu, SW | 1 |
| Li, GR | 1 |
| Novakovic, A | 1 |
| Gojkovic-Bukarica, L | 1 |
| Peric, M | 2 |
| Nezic, D | 1 |
| Djukanovic, B | 2 |
| Markovic-Lipkovski, J | 1 |
| Heinle, H | 1 |
| Shibasaki, K | 1 |
| Arai, Y | 1 |
| Uchida, W | 1 |
| Okazaki, T | 1 |
| Asano, M | 1 |
| Takenaka, T | 1 |
| Gojkoviíc Bukarica, L | 1 |
| Kazić, T | 1 |
| Sajić, Z | 1 |
| Panić, G | 1 |
| Bojić, M | 1 |
| Brandt, MC | 1 |
| Priebe, L | 1 |
| Böhle, T | 1 |
| Südkamp, M | 1 |
| Beuckelmann, DJ | 1 |
| Antzelevitch, C | 1 |
| Sicouri, S | 1 |
| Litovsky, SH | 1 |
| Lukas, A | 1 |
| Krishnan, SC | 1 |
| Di Diego, JM | 1 |
| Gintant, GA | 1 |
| Liu, DW | 1 |
| Miyawaki, N | 1 |
| Furuta, T | 1 |
| Shigei, T | 1 |
| Yamazaki, F | 1 |
| Yamauchi, H | 1 |
1 review available for 4-aminopyridine and Coronary Disease
| Article | Year |
|---|---|
Heterogeneity within the ventricular wall. Electrophysiology and pharmacology of epicardial, endocardial, and M cells.
Topics: 4-Aminopyridine; Action Potentials; Age Factors; Amiloride; Animals; Caffeine; Calcium; Calcium Chan | 1991 |
6 other studies available for 4-aminopyridine and Coronary Disease
| Article | Year |
|---|---|
Inhibition of ultra-rapid delayed rectifier K+ current by verapamil in human atrial myocytes.
Topics: 4-Aminopyridine; Adult; Aged; Coronary Disease; Heart Atria; Humans; Kinetics; Membrane Potentials; | 2004 |
The mechanism of endothelium-independent relaxation induced by the wine polyphenol resveratrol in human internal mammary artery.
Topics: 4-Aminopyridine; Anti-Arrhythmia Agents; Charybdotoxin; Coronary Artery Bypass; Coronary Disease; Gl | 2006 |
Antianginal effects of YM430, a novel calcium entry-blocking and beta-adrenoceptor-blocking agent in several experimental angina models.
Topics: 4-Aminopyridine; Adrenergic beta-Antagonists; Amifampridine; Angina Pectoris; Animals; Calcium Chann | 1997 |
The effects of levcromakalim and pinacidil on the human internal mammary artery.
Topics: 4-Aminopyridine; Adenosine Triphosphate; Apamin; Charybdotoxin; Coronary Artery Bypass; Coronary Dis | 1997 |
The ultrarapid and the transient outward K(+) current in human atrial fibrillation. Their possible role in postoperative atrial fibrillation.
Topics: 4-Aminopyridine; Aged; Atrial Fibrillation; Cells, Cultured; Coronary Disease; Electrophysiology; Fe | 2000 |
Anti-ischaemic and vasospasmolytic effects of a novel Ca2+ channel blocker, SD-3211, in vitro.
Topics: 4-Aminopyridine; Amifampridine; Animals; Arteries; Calcium Channel Blockers; Coronary Disease; Coron | 1991 |